Advisory Research’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-65,280
Closed -$15K 420
2022
Q2
$15K Hold
65,280
﹤0.01% 341
2022
Q1
$27K Hold
65,280
﹤0.01% 378
2021
Q4
$58K Buy
+65,280
New +$68.5K ﹤0.01% 327

Other funds holding AAC.WS

Advisory Research's AAC.WS Position: Q3 2022 in Review

Advisory Research sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q3 2022, closing a stake of 65,280 shares — an estimated $15K sold.

Advisory Research first reported a position in AAC.WS in Q4 2021 and held it in 3 quarters. The position peaked at $58K in Q4 2021. 79 funds tracked by Wall St. Rank hold AAC.WS as of Q3 2022.

  • Advisory Research reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Advisory Research sold 65,280 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $15K.
  • Advisory Research first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 3 quarters.
  • Advisory Research's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $58K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.